Ascendis Pharma (ASND) Stock
Ascendis Pharma (ASND) closed at $271.73 on Nov 16, 2026; its Tenet Score is 53 of 100 against 340 Healthcare peers.
32 figures withheld by our checks. Each blank figure names its reason.
Key stats
- Close
- $271.73
- Nov 16, 2026
- Market cap
- $16.8B
- share price × the latest quarter's diluted weighted-average share count (vendor)
- 52-week range
- 188.08 – 282.15
- low → high · as of close, Nov 16, 2026
- Tenet Score
- 53/100
- Mixed · 340 Healthcare peers
Industry: Drugs
Ascendis Pharma A/S scores 53/100. Mixed. Strongest on financial health and growth, value is the soft spot versus 340 Healthcare peers.
Tenet Score · vs sector
n=340Factor grades
Price
The whole report, at a glance · every card is a live peek, click any to open the section
- ~ Piotroski F-Score
- ✕ Graham Defensive
- ✕ Quality Compounder
- ✕ Drawdown Context
- ✕ Reversal Evidence
- ✓ Not-a-Value-Trap Gate
Ascendis Pharma A/S, operates as a biopharmaceutical company that focuses on developing TransCon-based therapies for unmet medical needs in Europe, the United States, and internationally. The company offers SKYTROFA for treating pediatric patients with grow…
Similar-sized companies in Drugs
The 10 companies in this industry closest in market cap, as of Nov 16, 2026.
| Company | Tenet Score | Market cap |
|---|---|---|
| United Therapeutics CorpUTHR | 72 | $25.0B |
| Incyte Corp.INCY | 60 | $24.5B |
| Alnylam Pharmaceuticals IncALNY | 52 | $21.4B |
| Medpace Holdings IncMEDP | 59 | $18.1B |
| Neurocrine Biosciences, Inc.NBIX | 65 | $16.7B |
| Exelixis IncEXEL | 74 | $16.6B |
| Jazz Pharmaceuticals plcJAZZ | 47 | $15.4B |
| Elanco Animal Health IncELAN | 37 | $13.2B |
| Dr. Reddy's Laboratories Ltd.RDY | 45 | $12.3B |
| Bio-Techne CorpTECH | 51 | $11.4B |
Common questions
What sector and industry is Ascendis Pharma in?
Ascendis Pharma is in the Healthcare sector and the Drugs industry.
What is Ascendis Pharma's Tenet Score?
Ascendis Pharma's Tenet Score is 53 out of 100, ranked against 340 Healthcare peers as of Nov 16, 2026.




